Modulation of the Neuro–Cancer Connection by Metabolites of Gut Microbiota
Biomolecules,
Journal Year:
2025,
Volume and Issue:
15(2), P. 270 - 270
Published: Feb. 12, 2025
The
gut-brain-cancer
axis
represents
a
novel
and
intricate
connection
between
the
gut
microbiota,
neurobiology,
cancer
progression.
Recent
advances
have
accentuated
significant
role
of
microbiota
metabolites
in
modulating
systemic
processes
that
influence
both
brain
health
tumorigenesis.
This
paper
explores
emerging
concept
metabolite-mediated
modulation
within
connection,
focusing
on
key
such
as
short-chain
fatty
acids
(SCFAs),
tryptophan
derivatives,
secondary
bile
acids,
lipopolysaccharides
(LPS).
While
microbiota's
impact
immune
regulation,
neuroinflammation,
tumor
development
is
well
established,
gaps
remain
grasping
how
specific
contribute
to
neuro-cancer
interactions.
We
discuss
with
potential
implications
for
neurobiology
cancer,
indoles
polyamines,
which
yet
be
extensively
studied.
Furthermore,
we
review
preclinical
clinical
evidence
linking
dysbiosis,
altered
metabolite
profiles,
tumors,
showcasing
limitations
research
gaps,
particularly
human
longitudinal
studies.
Case
studies
investigating
microbiota-based
interventions,
including
dietary
changes,
fecal
transplantation,
probiotics,
demonstrate
promise
but
also
indicate
hurdles
translating
these
findings
therapies.
concludes
call
standardized
multi-omics
approaches
bi-directional
frameworks
integrating
microbiome,
neuroscience,
oncology
develop
personalized
therapeutic
strategies
patients.
Language: Английский
From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents
Hesham M. Hassan,
No information about this author
Roket Hassan,
No information about this author
Ranya Mohammed Elmagzoub
No information about this author
et al.
Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(1), P. 72 - 72
Published: Jan. 9, 2025
Ciprofloxacin,
a
widely
used
second-generation
fluoroquinolone
for
treating
bacterial
infections,
has
recently
shown
notable
anticancer
properties.
This
review
explores
progress
in
developing
ciprofloxacin
derivatives
with
properties,
emphasizing
key
structural
changes
that
improve
their
therapeutic
effectiveness
by
modifying
the
basic
group
at
position
7,
carboxylic
acid
3,
or
both.
It
further
investigates
mechanisms
which
these
fight
cancer,
such
as
inducing
apoptosis,
arresting
cell
cycle,
inhibiting
topoisomerase
I
and
II,
preventing
tubulin
polymerization,
suppressing
interleukin
6,
blocking
thymidine
phosphorylase,
multidrug
resistance
proteins,
hindering
angiogenesis.
Additionally,
it
outlines
future
directions,
enhancing
efficacy,
selectivity,
investigating
potential
synergy
other
chemotherapeutic
agents,
offering
promising
avenue
new
therapies
cancer.
Language: Английский
Pancreatic lipase inhibitors as anti-obesity agents: a review of recent chemical scaffolds and their pancreatic lipase inhibitory potential
Medicinal Chemistry Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 18, 2025
Language: Английский
Development of indole hybrids for potential lung cancer treatment-part I: nitrogen-containing six-membered aromatic heterocycles
Shijia Zhao,
No information about this author
Zhi Xu
No information about this author
Future Medicinal Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 17
Published: March 29, 2025
Lung
cancer
is
the
most
prevalent
invasive
malignancy
and
leading
cause
of
cancer-related
death.
Chemotherapy
vital
for
lung
therapy,
but
multidrug
resistance
responsible
majority
fatalities,
creating
an
imperative
demand
to
develop
novel
chemotherapeutics.
Indole
a
valuable
anti-lung
pharmacophore
since
its
derivatives
could
act
on
cells
through
various
mechanisms.
Notably,
indole
hybrids
inhibit
multiple
targets
simultaneously
have
potential
overcome
shortcomings
traditional
Moreover,
many
such
as
indole-pyrimidine
hybrid
osimertinib
indole-hydroxamic
acid
panobinostat,
are
either
under
clinical
evaluations
or
already
been
approved
therapy.
This
indicates
that
rational
design
represents
highly
prospective
approach
development
new
chemotherapeutic
agents.
review
focuses
exploring
therapeutic
delves
into
their
action
mechanisms
well
structure-activity
correlations,
covering
articles
published
between
2021
present.
The
ultimate
goal
offer
foundation
in
future.
Language: Английский
Development of indole hybrids for potential lung cancer treatment - part II
Shanshan Huang,
No information about this author
Zhi Xu,
No information about this author
Yafei Zhuang
No information about this author
et al.
Future Medicinal Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 17
Published: March 30, 2025
Lung
cancer
has
become
the
most
prevalent
for
past
three
decades,
and
5-years
survival
rate
of
lung
is
only
~20%
nowadays.
Chemotherapy
mainstay
therapy,
especially
non-small
cell
cancer.
However,
drug
resistance
represents
a
principal
cause
therapeutic
failure
in
leading
to
insensitivity,
tumor
recurrence,
disease
progression.
Indole
hybrids
have
potential
conquer
resistance,
enhance
efficacy,
reduce
adverse
events,
improve
pharmacokinetic
properties
due
their
capacity
inhibit
multiple
targets
simultaneously.
Moreover,
indole
osimertinib,
mobocertinib,
cediranib,
vizimpro
are
currently
applied
clinics
demonstrating
that
valuable
scaffolds
treatment
eradication
This
review
provides
comprehensive
overview
evolving
landscape
with
vitro
vivo
efficacy
against
cancer,
structure–activity
relationships
as
well
mechanisms
action
also
discussed,
covering
articles
published
from
2021
onward.
Language: Английский
An insight into the therapeutic impact of quinoxaline derivatives: Recent advances in biological activities (2020–2024)
Aly M. Waseem,
No information about this author
Ranya Mohammed Elmagzoub,
No information about this author
Mervat Mohammed Mazhar Abdelgadir
No information about this author
et al.
Results in Chemistry,
Journal Year:
2024,
Volume and Issue:
unknown, P. 101989 - 101989
Published: Dec. 1, 2024
Language: Английский
Bisindole Compounds—Synthesis and Medicinal Properties
Antibiotics,
Journal Year:
2024,
Volume and Issue:
13(12), P. 1212 - 1212
Published: Dec. 13, 2024
The
indole
nucleus
stands
out
as
a
pharmacophore,
among
other
aromatic
heterocyclic
compounds
with
remarkable
therapeutic
properties,
such
benzimidazole,
pyridine,
quinoline,
benzothiazole,
and
others.
Moreover,
series
of
recent
studies
refer
to
strategies
for
the
synthesis
bisindole
derivatives,
various
medicinal
antimicrobial,
antiviral,
anticancer,
anti-Alzheimer,
anti-inflammatory,
antioxidant,
antidiabetic,
etc.
Also,
natural
are
mentioned
in
literature
their
biological
properties
starting
point
related
bisindoles.
Drawing
from
these
data,
we
have
proposed
this
review
provide
an
overview
techniques
qualities
bisindolic
that
been
2010
2024
well
numerous
uses
chemistry
materials,
nanomaterials,
dyes,
polymers,
corrosion
inhibitors.
Language: Английский
Neuroprotective Potential of Indole-Based Compounds: A Biochemical Study on Antioxidant Properties and Amyloid Disaggregation in Neuroblastoma Cells
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(12), P. 1585 - 1585
Published: Dec. 23, 2024
Based
on
the
established
neuroprotective
properties
of
indole-based
compounds
and
their
significant
potential
as
multi-targeted
therapeutic
agents,
a
series
synthetic
indole–phenolic
was
evaluated
multifunctional
neuroprotectors.
Each
compound
demonstrated
metal-chelating
properties,
particularly
in
sequestering
copper
ions,
with
quantitative
analysis
revealing
approximately
40%
chelating
activity
across
all
compounds.
In
cellular
models,
these
hybrid
exhibited
strong
antioxidant
cytoprotective
effects,
countering
reactive
oxygen
species
(ROS)
generated
by
Aβ(25–35)
peptide
its
oxidative
byproduct,
hydrogen
peroxide,
showing
average
25%
increase
cell
viability
reduction
ROS
levels
to
basal
states.
Further
using
thioflavin
T
fluorescence
assays,
circular
dichroism,
computational
studies
indicated
that
synthesized
derivatives
effectively
promoted
self-disaggregation
fragment.
Taken
together,
findings
suggest
unique
profile
actions
for
derivatives,
combining
chelating,
antioxidant,
anti-aggregation
which
position
them
promising
development
agents
Alzheimer’s
disease
therapy.
The
methods
used
provide
reliable
vitro
data,
although
further
vivo
validation
assessment
blood–brain
barrier
penetration
are
needed
confirm
efficacy
safety.
Language: Английский